Aller au contenu
Aperlena
Langue:

Norway - Laboratory, optical and precision equipments (excl. glasses) - Equipment for weekend sequencing for the Department of Medical Genetics at UNN HF Tromsø.

Attribué Avis d'attribution Aucune date limite publiée
Suivre ce marché

Les offres sont closes. Une attribution ou un rectificatif sur cet avis : un e-mail quand le registre le voit. Se connecter

  1. Publié
  2. Attribué en attente

Description

The Medical Genetics Department at the University Hospital of North Norway (UNN) shall procure a sequentialator from PacBio to read long fragments of DNA and RNA sequencing (long-read sequencing, LRS). The instruments shall be used for diagnostics and shall replace and supplement the current diagnostics based on short-read sequencing (SRS). This is because LRS detects some types of genetic variation better than SRS, e.g. major structural deviations and methylation status. Method transfer shall therefore be carried out from the current SRS to a new LRS for selected medical indications and it is therefore very important that these sequentators deliver a sequence of very high quality and reproducibility. Of the above mentioned reasons, PacBio, as far as the contracting authority is aware of, is the only supplier who can fulfil the requirements. The terms in PPR § 13-4 (b) no. 2 are considered fulfilled. The Medical Genetics Department at the University Hospital of North Norway (UNN) intends to procure 1 sequentialator from PacBio to read long fragments of long-read sequencing (DNA and RNA sequencing). The instruments shall be used for diagnostics and shall replace and supplement the current diagnostics based on short-read sequencing (SRS). This is because LRS detects some types of genetic variation better than SRS, e.g. major structural deviations and methylation status. Method transfer shall therefore be carried out from the current SRS to a new LRS for selected medical indications and it is therefore very important that these sequentators deliver a sequence of very high quality and reproducibility. There are several technical specifications that are decisive for achieving the quality we need for this purpose, for example: - The sequencing must be able to carry out sequencing with long read lengths of DNA and RNA for clinical samples. The read length of sequential fragments must at least be median 10-15 kb. At least 90% of the bases must have a quality of Q30 or higher in a typical 30X human genome. The instrument shall be particularly suitable for detecting major structural deviations and methylation status. - The data quality of SNP variants and short parts <50 bp must be at least as good as that achieved by Illumina SRS. This is important so that the analytical sensitivity of the analysis offer is not reduced for these types of variants and that the quality of the analysis offer is not, therefore, impaired for the patient analyses that shall only be carried out on a new long-read sequentator. - Sensitivity and precision must be documented in a reference dataset for the entire genome (i.e. not just the encoded areas in the genome) with the following parameters met: (i) F1 score > 99 % for SNS. (ii) F1 score > 95 % for INDEL's. (iii) F1 score >90 % for structural variants (SV's). (iv) Recall or F1-score for SNVs and INDEL are for technically challenging medical relevant genes (CMRG, as defined in Wagner et al., Nature Biotechnology 2022: https://www.nature.com/articles/s41587-021-01158-1) at least on par with Illumina SRS. High F1 scores (low false positive and negative variant detection) are decisive in avoiding extremely time-consuming and resource-demanding downstream verification of variants/missing cause variants. - Variantcalling to the mentioned standards must be achieved with an average 30X sequencing depth. This is required to avoid the need for deeper sequencing, including duotone readings, in order to achieve the necessary data quality. The need for deeper sequencing will increase the costs and time consumption, which is not acceptable. - Sequence data cannot have systematic bias in basecalling and variant calculation, including in homopolymer areas. Of the above mentioned reasons, PacBio, as far as the contracting authority is aware of, is the only supplier who can fulfil the requirements. The terms in PPR § 13-4 (b) no. 2 are considered fulfilled.

Source officielle

Source : TED - Tenders Electronic Daily (Publications Office of the EU)

Vérifiez toujours les détails dans l'avis officiel.

Dernière vérification auprès de TED - Tenders Electronic Daily (Publications Office of the EU) il y a 1 mois

Consulter l'avis officiel

Plus de cet acheteur

Profil complet de l'acheteur

85 marchés ouverts actuellement

Attributions récentes

Historique des modifications

Chaque republication de cet avis par une source officielle avec un contenu différent. Nous surveillons toutes les sources que nous indexons, y compris les copies régionales du même avis.

  1. A lire avant de repondre
    • Objet et critères: La description a été étoffée. À relire avant de repondre.

Suivez ce marche et nous vous ecrivons dès qu'il change. Créer un compte

Marchés similaires

Contexte de marché

Appel ouvert moyen · Équipements de laboratoire & de précision
5 436 762 €
2 032 ouverts en Europe actuellement
Historique de l'acheteur sur Aperlena
775 avis suivis · 161 attribués
170 986 269 € de contrats attribués

Ne manquez plus aucun marché comme celui-ci

11 nouveaux avis pour Équipements de laboratoire & de précision en Norvège au cours des 7 derniers jours. Recevez un e-mail quand de nouveaux avis paraissent. Gratuit.

Créer mon alerte
Source

Raccourcis clavier

Parcourir une liste sans toucher la souris. Les raccourcis restent inactifs pendant la saisie dans un champ.

j
Résultat suivant
k
Résultat précédent
Entrée
Ouvrir le résultat
n
Page suivante
p
Page précédente
c
Comparer ce résultat
s
Ajouter ce résultat à la présélection
/
Aller au champ de recherche
?
Afficher ces raccourcis
Échap
Fermer